Article info
PDFNeurogenetics
Research paper
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial
- Correspondence to Dr Yoshihide Sunada, Department of Neurology, Kawasaki Medical School, Kurashiki 701-0192, Japan; ysunada{at}med.kawasaki-m.ac.jp
Citation
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial
Publication history
- Received January 5, 2018
- Revised March 28, 2018
- Accepted March 29, 2018
- First published April 17, 2018.
Online issue publication
January 13, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/